Research Agenda in Childhood Impairing Emotional Outbursts: A Report of the AACAP Presidential Taskforce on Emotional Dysregulation. 2025; 3:147-155.
.Patterns in Medication Use for Treatment of Depression in Autistic Spectrum Disorder. Journal of Autism and Developmental Disorders. 2025; 55:1969-1975.
.Springer Nature; Springer Nature; 2025.
. Fragile X Syndrome. Neuropsychiatric Care for Genetic Syndromes and Other Neurodevelopmental Disorders. :Accelerated Theta Burst Transcranial Magnetic Stimulation for Refractory Depression in Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 2025; 55:940-954.
.Dual Diagnosis of Fragile X Syndrome and DEPDC5-Related Disorder Emphasizes DEPDC5's Role Beyond Familial Epilepsy: A Case Report and Literature Review. Editor, Das SP. Case Reports in Genetics. 2025; 2025:4501466.
.Probing the Neurodynamic Mechanisms of Cognitive Flexibility in Depressed Individuals with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. 2025; 35:231-243.
.Results from a Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Trial of Lovastatin or Minocycline in Fragile X Syndrome. Journal of Child and Adolescent Psychopharmacology. 2025; 35:211-221.
.Health Related Quality of Life in Autistic Youth and Their Families. Journal of Autism and Developmental Disorders. 2025; 55:1982-1987.
.Transdermal Asenapine for Agitation and Irritability in a Child With Complete Intravenous Dependence. Journal of the American Academy of Child and Adolescent Psychiatry. 2025; 64:89-91.
.Deprescribing Antidepressants in Children and Adolescents: A Systematic Review of Discontinuation Approaches, Cross-Titration, and Withdrawal Symptoms. Journal of Child and Adolescent Psychopharmacology. 2025; 35:3-22.
.Springer Nature; Springer Nature; 2025.
. Psychopharmacology in Autism. Handbook of Evidence-Based Practices in Autism Spectrum Disorder. :